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Background: Cutaneous leishmaniasis (CL) is one of the common tropical protozoal diseases caused by various
Leishmania species, and transmitted by the sand-fly vectors, Phlebotomus and Lutzomyia species. Herein, we report
for the first time a case of CL that presented as large eczematous plaques occurring on the dorsi of both feet in a
Libyan drug addicted, alcoholic patient with HIV infection.
Findings: A 34 year-old HIV-positive, alcoholic, drug addicted Libyan male presented to us with a history of a
non-itchy skin lesions on the dorsi of both feet of 5-weeks duration. Systemic and topical antibiotics were given
without improvement. Diagnosis of this patient was confirmed by observation of Leishmania amastigote bodies
in stained slit-skin smear skin biopsy. After parenteral administration of sodium stiboglyconate (Pentostam)
(20 mg/kg/day) for 28 days the lesions did not show any marked improvement. Concurrently, combination therapy
of oral rifampicin (600 mg/day) and isoniazide (300 mg/day) was given for 8 weeks. Complete healing of lesions was
achieved after this treatment and skin-slit smears turned negative.
Conclusions: Localized cutaneous leishmaniasis should be remembered in deferential diagnosis of unresponsive
contact dermatitis especially for HIV-positive patients in CL endemic areas.
This patient was not responding to Pentostam therapy, which is not very common in Libya. Interestingly, combination
of oral rifampicin (600 mg/day) and isoniazide (300 mg/day) can be a successful alternative therapy.
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A 34 year-old HIV-positive, alcoholic, drug addicted Libyan
male presented to us with a history of non itchy skin lesions
on the dorsi of both feet of 5-weeks duration. The lesions
started as small non itchy papules which gradually in-
creased in size and then ulcerated with offensive odour.
The patient applied warm onion to treat the lesions, which
turned painful and for that he sought medical advice. Sys-
temic and topical antibiotics were given without improve-
ment. The patient denied history of trauma, insect bite,
unbalanced diabetes, or allergic diseases and no family his-
tory of the same illness.
On examination, there were bilateral asymmetrical
large well-defined erythematous ulcerated plaques with
pus discharge and crusts involving the dorsal surface of
both feet and left big toe. Yellowish brown discoloration* Correspondence: aamro@pharm.alquds.edu
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unless otherwise stated.of the surrounding skin and nails was noticed (Figure 1).
In addition, we noticed the presence of painless crusted
nodules over the anterior aspect of the right ankle joint
and left cheek (Figure 1). No palpable subcutaneous
nodules or regional lymph nodes were detected. The pa-
tient had a coated tongue and seborrheic dermatitis over
his scalp, face and chest. KOH for Candida albicans
examination was positive from tongue and negative from
nails. Routine laboratory tests showed low leukocyte
count (3.5 × 103/ul), lymphopenia (16.6%), low platelets
(132 × 103/ul), CD-4 T-cell count was lower than (15/
ul), and positive serology for HIV and hepatitis C. Other
routine investigations were normal including chest X-ray
and ECG. Histopathological features revealed focal
hyperkeratosis and focal parakeratosis. Stratum spongi-
osum showed intercellular oedema, local necrosis, and
moderate acanthosis. Dermis showed diffuse and nodu-
lar mixed cellular infiltration with many extravasated
RBCs (Figure 2). No characteristic tubercular granu-
lomas were seen. The clinical picture was consistental Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Painless crusted nodule over left cheek at angle of mandible and bilateral asymmetrical large well-defined erythematous ulcerated
plaques with crusts over dorsi of feet (left images). Complete healing after two months treatment by Rifampicin and Isoniazide (right images).
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infection. However, a 2 mm punch biopsy and slit-skin
smear was obtained from all lesions. Smears were fixed
and stained with Giemsa’s stain. Leishmania parasites
were heavily seen inside and outside infected macro-
phages (Figure 2). Molecular identifications of the
causative Leishmania species by amplifying the internal
transcribed spacer1 (ITS1-PCR) [1] failed due to PCR
inhibition problems. After parenteral administration of
sodium stiboglyconate (Pentostam) (20 mg/kg/day) for
28 days the lesions did not show any marked improve-
ment, and skin-slit smears were positive for LeishmaniaFigure 2 Intra-and extra cellular Leishmania parasites as shown in Gie
lesions obtained from dorsal surface of right foot (right).parasites after this period. The patient was referred to
the infectious department for antiretroviral therapy and
further HIV care. Concurrently, combination therapy of
oral Rifampicin (600 mg/day) and Isoniazide (300 mg/
day) was given for 8 weeks. Complete healing of lesions
was achieved after this treatment and skin-slit smears
turned negative (Figure 1).
Cutaneous leishmaniasis (CL) is one of the common
tropical protozoal diseases caused by various Leishmania
species, and transmitted by the sand-fly vector of Phlebo-
tomus and Lutzomyia species. About 1.5 million new cases
are reported each year, and over 350 million people live inmsa-stained slit-skin smear (Left). Histopathological findings of
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public health problem in Libya caused by L. major and L.
tropica [6]. Leishmania species can cause a wide spectrum
of cutaneous lesions such as localized cutaneous, muco-
cutaneous, diffuse cutaneous, or post-kala-azar dermal
leishmaniasis [7,8]. In HIV-positive patients: asymptom-
atic and mucosal leishmaniasis has been reported in
addition to other usual types [9]. However, HIV-positive
intravenous drug users (IVDUs) can be infected with Leish-
mania by sharing of contaminated syringes and needles
[9]. Clinical variation of leishmaniasis –HIV co-infection is
determined by parasite species and host cell mediated im-
munity (CMI) response [2]. Recently, clinical variants of
CL with or without HIV co-infection have been reported
such as; sporotrichoid, psoriasiform, warty, erysipeloid, im-
petigo like, cold cellulitis, zosteriform, acneiform, and ecze-
matoid variant [10-12]. The incidence of eczematoid
variant of localized CL seems not to be very common and
reported to be 2.3% [11].
Herein, we report for the first time a case of Pentos-
tam unresponsive CL that presented as large eczematous
plaques occurring on the dorsi of both feet in a Libyan
drug addicted patient with HIV infection. Localized CL
typically presented as papules, nodules, plaques, ulcerated
or crusted nodules. A contact dermatitis like morphology
of localized CL lesions is unusual. Diagnosis of CL was
confirmed by observation of parasites in stained slit-skin
smears. This patient was unresponsive to Pentostam, which
is not very common in Libya. Combination therapy of oral
rifampicin and isoniazide completely cured the lesions. This
combination therapy is used in Libya to treat cutaneous tu-
berculosis and to treat CL cases unresponsive to parenteral
administration of Pentostam [6]. A previous study by
Peters et al. [13] descried a striking remission of CL in
a Brazilian patient by using this combination. Small
scale studies on oral rifampicin treatment of CL have
shown a healing rate of 73.9%, 75% and 83.3% [14-16]
respectively. However, no clinical trial was carried out to
approve combination therapy of rifampicin and isoniazide
in treatment of CL [13].
The patient denied insect bites though he came from
Gabel Garby where CL is endemic, possibly the patient
was unnoticeably bitten during drug and alcohol intake.
According to ethical approval of this study, the patient
agreed to publish his photos and case history anonymously.
Written informed consent was obtained from the patient.
The study was revised and approved by (Research Ethics
committee, University of Tripoli, Libya).
Conclusion
The learning points from this short report is that localized
cutaneous leishmaniasis should be considered in differential
diagnosis of unresponsive contact dermatitis especially for
HIV-positive patients in CL endemic areas. A combinationof oral rifampicin (600 mg/day) and isoniazide (300 mg/
day) can be successful alternative therapy for Pentostam
unresponcive CL patients in Libya. However, this combi-
nation therapy has to be assessed at a larger scale.
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